• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nutriband Inc (NQ: NTRB )

    7.060 +0.180 (+2.62%)
    Streaming Delayed Price Updated: 11:52 AM EDT, Oct 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,820
    Open 6.920
    Bid (Size) 6.620 (1)
    Ask (Size) 7.060 (1)
    Prev. Close 6.880
    Today's Range 6.600 - 7.120
    52wk Range 1.530 - 9.595
    Shares Outstanding 6,356,270
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Are Pharma Stocks Harmful To Your Financial Health ?
    It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label. 
    Via Talk Markets
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A Session
    Via Investor Brand Network

    Performance

    YTD
    +205.09%
    +205.09%
    1 Month
    +72.62%
    +72.62%
    3 Month
    +19.86%
    +19.86%
    6 Month
    +59.01%
    +59.01%
    1 Year
    +201.71%
    +201.71%

    More News

    Read More
    Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17
    Via ACCESSWIRE
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
    Via FinancialNewsMedia
    Exposures Product Safety
    NTRB Stock Earnings: Nutriband Reported Results for Q1 2024
    Via InvestorPlace
    As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
    From FN Media Group LLC
    Via GlobeNewswire
    NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY
    Via FinancialNewsMedia
    Topics Intellectual Property
    Exposures Intellectual Property
    Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology
    Via ACCESSWIRE
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product
    Via Investor Brand Network
    Women Reach Settlement After Yale Nurse Switched Painkillers with Saline Solution
    Via Investor Brand Network
    Topics Lawsuit
    Exposures Financial Legal
    Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch
    Via ACCESSWIRE
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Reports on Share Repurchase Program
    Via Investor Brand Network
    Microsoft, Intel And 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    Nutriband Inc. Authorizes $1M Share Buyback Program
    Via ACCESSWIRE
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update
    Via Investor Brand Network
    Exposures Product Safety
    Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
    Via ACCESSWIRE
    Proposed US Law Would Direct Opioid Settlement Cash to Opioid Crisis Management
    Via Investor Brand Network
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Execs to Participate in July 25 Investor Webinar
    Via Investor Brand Network
    Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
    Via ACCESSWIRE
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Obtains Notice of Allowance for Key Trademark Identified as ‘Integral’ to Platform Technology
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology
    Via ACCESSWIRE
    BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Shares Update on Its AVERSA(TM) Fentanyl Product Development Program
    Via Investor Brand Network
    Exposures Product Safety
    Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
    Via ACCESSWIRE
    BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q1 2024 Quarterly Report
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.